翻訳と辞書 |
Lumiliximab
Lumiliximab is a monoclonal antibody that targets CD23. It acts as an immunomodulator〔(International Nonproprietary Names for Pharmaceutical Substances (INN) ). ''World Health Organization''.〕 and, , it is being investigated in Phase I and II clinical trials for the treatment of chronic lymphocytic leukemia. The drug is a chimeric antibody from ''Macaca irus'' and ''Homo sapiens''.〔 == References == 〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Lumiliximab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|